Want to join the conversation?
Pharmacy company $CVS said that 2Q16 adjusted EPS rose 8.3% to $1.32. This is $0.01 above the high end of the guidance. Excluding acquisition-related costs in both years, operating profit rose 6.5% enterprise-wide, with operating profit Retail/LTC segment in line with company expectations and operating profit in the PBM exceeding expectations.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?